Thomas H. Kean
Trade Performance Intelligence
Score: 5/10Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
5 flagsRep. Kean bought $1,001 - $15,000 in $AMZN on 2025-05-08, 14 days before the Access Technology Affordability Act of 2025 (S1918) was introduced, which could benefit Amazon.
Rep. Kean bought $1,001 - $15,000 in $BDX on 2025-05-13, 21 days before the SEPSIS Act (S1929) was introduced, which could create new revenue streams for medical diagnostics.
Rep. Kean bought $1,001 - $15,000 in $TMO on 2025-05-05, 29 days before the SEPSIS Act (S1929) was introduced, which could create new revenue streams for medical diagnostics.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $AMZN | Amazon.com, Inc. - Common Stock | $1K-$15K | — | — | — | May 8, 2025 |
| BUY | $AON | Aon plc Class A Ordinary Shares | $1K-$15K | — | — | — | May 27, 2025 |
| BUY | $BDX | Becton, Dickinson and Company Common Stock | $1K-$15K | — | — | — | May 13, 2025 |
| BUY | $TMO | Thermo Fisher Scientific Inc Common Stock | $1K-$15K | — | — | — | May 5, 2025 |
| PARTIAL SELL | $CCK | Crown Holdings, Inc. | $1K-$15K | — | — | — | May 8, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Extreme Heat Economic Study Act of 2025
The Extreme Heat Economic Study Act of 2025 (HR3702) has been introduced in the House, mandating an economic impact study on extreme heat. While not directly funding, this bill establishes a policy directive that could increase future demand for climate risk data, analysis, and reporting services, benefiting consulting, technology, and insurance firms. The bill is in an early stage, referred to committee, with a companion bill in the Senate.
DeOndra Dixon INCLUDE Project Act of 2025
The DeOndra Dixon INCLUDE Project Act of 2025 (HR3491) has been introduced in the House and referred to the Committee on Energy and Commerce. This bill authorizes the NIH to establish a dedicated program for Down syndrome research, which could increase demand for genetic sequencing, diagnostic services, and pharmaceutical development. While the bill does not appropriate funds, it sets the framework for future funding opportunities.
CREATE JOBS Act
The CREATE JOBS Act (S.2056) proposes to permanently reinstate 100% bonus depreciation, allowing businesses to immediately deduct the full cost of capital investments. This bill, if enacted, would provide a significant tax incentive for companies across all sectors to increase capital expenditures. The bill is currently in the early stages, having been referred to the Senate Committee on Finance.
Lowering Broadband Costs for Consumers Act of 2025
The 'Lowering Broadband Costs for Consumers Act of 2025' (HR4032) mandates increased Universal Service Fund contributions from broadband and 'edge providers,' directly raising operating costs for major internet service providers and large technology companies. This will reduce profit margins for affected companies. The bill is in the early stages, having been referred to committee, but has a companion bill (S1651) and 23 cosponsors, indicating moderate legislative momentum.
Price Gouging Prevention Act of 2025
The Price Gouging Prevention Act of 2025 directly limits corporate profitability for large-cap companies during 'exceptional market shock' events by mandating pre-shock margin maintenance. This legislation increases regulatory risk and caps potential upside for companies with significant market power across all sectors, leading to decreased profitability during crises. All major corporations face reduced profit potential and increased compliance costs.
Access Technology Affordability Act of 2025
The Access Technology Affordability Act of 2025 introduces a refundable tax credit of up to $2,000 every three years for the purchase of qualified access technology for blind individuals. This directly increases consumer purchasing power for specific technology products, creating a new demand channel for companies in the assistive technology space.
STOP CSAM Act of 2025
The STOP CSAM Act of 2025 (S.1829) has advanced to the Senate Legislative Calendar, increasing the likelihood of passage. This bill directly increases liability and compliance costs for online platforms, which will reduce profit margins for major online service providers. Affected companies, including Alphabet, Meta Platforms, Microsoft, Amazon, Twilio, Verizon, and AT&T, face increased operational expenses due to mandated content moderation and reporting systems.
Streamlining Federal Cybersecurity Regulations Act of 2025
The Streamlining Federal Cybersecurity Regulations Act of 2025 (S.1875) aims to unify federal cybersecurity requirements, which could simplify compliance for established cybersecurity and cloud service providers. The bill is in its early stages, having been introduced and referred to committee on May 22, 2025, and does not contain explicit funding authorizations. This legislative effort could reduce regulatory burdens for companies operating in the federal cybersecurity space, but its impact is long-term and contingent on passage.
IGNITEACTION LLC: $16.1M Department of Commerce Contract
This $16.1 million contract to IGNITEACTION LLC for cloud infrastructure support at the U.S. Census Bureau represents a steady demand for IT modernization services, likely benefiting major cloud providers and IT consulting firms. While IGNITEACTION is private, this award signals continued federal investment in cloud migration, a positive trend for the broader technology sector.
SEPSIS Act
The SEPSIS Act (S.1929) establishes new federal programs for sepsis research, diagnosis, and treatment, creating new revenue streams for medical diagnostics, device manufacturers, and clinical research companies. Senate Majority Leader Schumer's sponsorship and a House companion bill (HR7116) indicate strong legislative momentum for this early-stage bill. The bill does not specify a funding amount, but authorizes programs that would require future appropriations.
Live Charts
Other Filings by Thomas H. Kean
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.